Aviance Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Aviance Capital Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21,581	Closed	-$844K	–	211
2016 Q4	$844K	Sell	21,581 -3,838	-15%	-$156K	0.04%	132
2016 Q3	$1.12M	Sell	25,419 -6,192	-20%	-$281K	0.03%	200
2016 Q2	$1.32M	Sell	31,611 -1,032	-3%	-$43.7K	0.04%	179
2016 Q1	$1.31M	Buy	32,643 +1,060	+3%	+$44.9K	0.04%	152
2015 Q4	$1.62M	Buy	31,583 +4,081	+15%	+$208K	0.05%	138
2015 Q3	$1.29M	Buy	+27,502	New	+$1.66M	0.05%	141
2015 Q2	–	Sell	-14,028	Closed	-$866K	–	248
2015 Q1	$866K	Buy	14,028 +1,078	+8%	+$63.9K	0.03%	152
2014 Q4	$699K	Buy	12,950 +1,366	+12%	+$74.6K	0.03%	192
2014 Q3	$614K	Buy	11,584 +2,636	+29%	+$134K	0.02%	213
2014 Q2	$464K	Buy	+8,948	New	+$432K	0.02%	234

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Aviance Capital Management's XPH Position: Q1 2017 in Review

Aviance Capital Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2017, closing a stake of 21,581 shares — an estimated $844K sold.

Aviance Capital Management first reported a position in XPH in Q2 2014 and held it in 10 quarters. The position peaked at $1.62M in Q4 2015. 79 funds tracked by Wall St. Rank hold XPH as of Q1 2017.

Aviance Capital Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2017 after selling out during the quarter.
Aviance Capital Management sold 21,581 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2017, an estimated $844K.
Aviance Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2014 and held it in 10 quarters.
Aviance Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.62M in Q4 2015.
79 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2017.

Based on Aviance Capital Management's 13F filing for Q1 2017, filed 1 Jun 2017.